A CRISPR therapy for sickle cell disease and beta thalassemia looks close to 100% effective three years after infusion.
CRISPR cure for sickle cell nearly 100% effective after three years
Posted in biotech/medical
Posted in biotech/medical
A CRISPR therapy for sickle cell disease and beta thalassemia looks close to 100% effective three years after infusion.